DecisionPoint Financial’s Biogen BIIB Stock Holding History

DecisionPoint Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26K	Buy	6 +3	+100%	+$574	﹤0.01%	398
2026 Q1	$550	Hold	3	–	–	﹤0.01%	462
2025 Q4	$528	Hold	3	–	–	﹤0.01%	525
2025 Q3	$463	Hold	3	–	–	﹤0.01%	486
2025 Q2	$391	Buy	+3	New	+$374	﹤0.01%	502

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DecisionPoint Financial's BIIB Position: Q2 2026 in Review

DecisionPoint Financial increased its Biogen (BIIB) stake by 100% in Q2 2026, buying an estimated $574 and bringing the position to 6 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

DecisionPoint Financial first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

DecisionPoint Financial held 6 shares of Biogen worth $1.26K as of Q2 2026.
DecisionPoint Financial bought 3 Biogen shares in Q2 2026, an estimated $574.
Biogen made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #398 holding.
DecisionPoint Financial first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.